Legionella pneumophila has been shown to induce gamma interferon (IFN-,y) both in vitro and in vivo during experimental infections of mice. With complement-mediated serologic depletion of murine splenocytes, the cellular sources of IFN-'y following in vitro stimulation with L. pneumophila antigens were Thy-1.2+, Lyt-2-, L3T4-, and asialo-GM1+, which is consistent with the natural killer (NK) cell phenotype. Additionally, Percoll density discontinuous centrifugation demonstrated that maximal production of IFN coincided with high NK activity in fractions which were enriched for large granular lymphocytes. Furthermore, 18-to 24-h incubation of splenocytes with L. pneumophila whole-cell vaccine resulted in augmented NK cytotoxic activity against YAC-1 tumor target cells in a 51Cr release assay. The addition of macrophages to purified large granular lymphocyte populations augmented both IFN--y production and NK activity, suggesting that antigen is required for optimal responses. In an experimental infection model using an intratracheal inoculation route, NK activity was enhanced in the spleen, peripheral blood, and lung cells of infected mice, with maximal stimulation in the lung leukocytes at the site of infection. The results of the present study indicate that NK cells respond in vivo and in vitro to stimulation by L. pneumophila by producing IFN-y and by increased cytolytic activity.
Legionella pneumophila is a facultative gram-negative bacterium that has been identified as the etiologic agent of Legionnaires disease (23) . Studies in both humans and guinea pigs have shown that resistance to infections appears to depend to a greater extent on cell-mediated immunity than on humoral immunity. For example, the presence of antilegionella antibodies did not significantly increase the killing of the bacterium by human phagocytes (14, 15) , but treatment of monocytes with gamma interferon (IFN--y) was shown to inhibit the intracellular growth of the bacterium (2) .
IFNs are known to be antiviral, antitumor, and antiproliferative proteins which also have immunomodulatory properties (30) . Recent studies have indicated that IFN-y is similar, if not identical, to at least one of the macrophageactivating factors (31) . The addition of native or recombinant IFN--y to macrophage cultures resulted in activation of the macrophage, as shown by increased tumor cytolysis (8) , increased Ta antigen expression (33) , and increased Fc receptor numbers (11) . IFN has also been shown to upwardly modulate natural killer (NK) cell activity (34) .
NK cells have been identified in normal human and mouse lymphocyte populations as those cells capable of spontaneously lysing various neoplastic cells in vitro, and these cells may be important in tumor surveillance mechanisms and early defense against microbes (26) . IFNs appear to regulate NK activity in at least two ways. First, IFNs can trigger the conversion of a noncytotoxic cell into a cytotoxic cell. This can be monitored by the appearance of Lyt-5 antigen, a differentiation marker, on the surfaces of murine NK cells (26) . Second, IFNs can increase the activities of existing NK cells, presumably by accelerating the recycling event, which results in increased numbers of NK-sensitive target cells being lysed. In addition to their * Corresponding author. responses to IFNs, NK cells are also able to produce both IFN-(x and IFN-y (34) . This could result in amplifications of their effects once the NK cells are activated.
NK activity has been shown to be induced in vivo by intraperitoneal injections of live Listeria monocytogenes bacteria into mice (13) . From day 2 to day 6 postinoculation, high levels of NK activity were detected in the nonadherent populations of peritoneal exudate cells. The ability of nonadherent cells to produce IFN when stimulated in vitro with listerial antigens correlated with the levels of NK activity, although a causal relationship was not established. NK cell activity has also been reported to be modulated by in vivo exposure of mice to Corynebacterium parvum (7) . Either augmentation or depression of NK activity has been described, depending on the conditions of treatment. NK activity is augmented on day 1 to day 3 in the splenocytes of mice given C. parvum, but suppressor cells to NK activity are produced in mice by 5 to 7 days after treatment (24) . Human NK activity has also been reported to respond to bacterial stimulation. Incubation of glutaraldehyde-fixed Salmonella bacteria with high-density lymphocytes resulted in activation of NK-like cytotoxicity that was independent of IFN (32) . However, similar stimulation of low-density lymphocytes (a population enriched for NK cells) with bacteria appeared to involve IFN production (32) . The augmentation of NK activity by bacteria and their products could be a direct result of the induction of IFNs or interleukin 2 (IL-2), another potent activator of NK cells (12, 16 MATERIALS AND METHODS Animals and reagents. Inbred female BDF1 mice (Jackson Laboratory, Bar Harbor, Maine) were used for these studies. The animals were 8 to 10 weeks of age at the time of the experiments. The culture medium used for the murine splenocytes was RPMI 1640 (GIBCO Laboratories, Grand Island, N.Y.), supplemented with 10% fetal calf serum (Hyclone, Logan, Utah), 2 mM L-glutamine (GIBCO), penicillin, and streptomycin, and 5 x 10-5 M 2-mercaptoethanol (Sigma Chemical Co., St. Louis, Mo.), and will be referred to as complete medium. Recombinant human IL-2 was generously provided by Hoffmann-La Roche, Inc., Nutley, N.J. Recombinant murine IFN--y (specific activity, 1.03 x 107 U/mg) was provided by Genentech Corp., South San Francisco, Calif., and was derived from transfected Escherichia coli cultures.
Preparation of bacteria. L. pneumophila, serogroup 1, was obtained at autopsy from a case of fatal legionellosis at Tampa General Hospital, Tampa, Florida, and was grown on buffered charcoal yeast extract medium (GIBCO) agar plates at 35°C. To estimate the number of bacteria used for experiments, the optical density of a bacterial suspension was measured and compared with a standard suspension. The bacteria obtained from 48-h cultivation on buffered charcoal yeast extract medium plates were suspended in pyrogen-free phosphate-buffered saline (M. A. Biologics) and were diluted to the indicated concentrations. The concentration of bacterial CFUs in the suspension was verified by spread plate counts on duplicate plates. Formalin-killed whole-cell preparations, termed the vaccine, were prepared as described previously (5) .
i.t. inoculation of mice. The i.t. infections were performed as described by Joan Stein-Streilein, Miami, Florida (28) . A bacterial suspension (25 IlI) or control fluids were injected directly into the trachea of anesthetized animals, and the incision was closed with a surgical wound clip.
Preparation of splenocyte cultures. For the NK assays, spleen cell cultures were prepared by aseptically removing the organ and disrupting it in a stomacher (Tekmar, Cincinnati, Ohio) in 5 ml of Hanks balanced salt solution (HBSS) per spleen to obtain a single-cell suspension. The cells were washed several times in HBSS by centrifugation at 400 x g and were then suspended in complete medium at 107 cells per ml, unless otherwise specified. Splenocytes were separated into adherent or nonadherent cell populations by allowing the whole-spleen cell preparations to adhere to wells of 24-well plastic plates for 2 h at 37°C, by washing the wells with warm medium to remove the nonadherent cells, and by adding fresh medium to the adherent cells.
Preparation of lung leukocyte cultures. For NK activity, lung leukocytes from both control and infected mice were used. Lung tissues were removed from exsanguinated mice and were minced and processed in a stomacher to obtain cell suspensions, as described elsewhere (35) . These suspensions were passed through a wire screen to remove large chunks of tissue and were then centrifuged at 500 x g for 20 min over a cushion of Lympholyte-M (Cedarlane, Westbury, N.Y.) to remove parenchymal cells and debris. The leukocytes were collected from the HBSS-Lympholyte-M interface and were washed twice in HBSS. Cells were used at 1 x 106 cells per ml of complete medium. Usually, recovery of lung leukocytes ranged from 0.5 x 106 to 1.5 x 106 cells per animal from control mice to as many as 5 x 106 cells from L. pneumophila-infected mice.
Collection of lung lavage fluid. Lung lavage fluid for the IFN assay was collected as previously described (4) . Briefly, 1 ml of warm, complete medium was twice injected into lungs and withdrawn. The fluid was passed through a microfilter (pore size, 0.22 ,um; Millipore Corp., Bedford, Mass.) to remove bacteria, cells, and debris and was either used immediately for the assay or stored at -700C.
Collection of murine PBLs. Murine PBLs were obtained from both control and infected mice for determination of NK activity. Blood was collected via cardiac puncture by using a heparinized syringe with a 25-gauge needle from mice that were sacrificed in dry-ice chambers. The heparinized syringe was prepared by aspirating small volumes of sterile heparin at 1,000 U/ml into a tuberculin syringe and by then expressing all but the amount which remained in the needle hub. Typically, 0.5 to 0.8 ml of blood could be collected per animal. The blood was then diluted with an equal volume of HBSS and centrifuged over a cushion of Lympholyte-M, as described for the recovery of lung leukocytes. PBLs were collected from the fluid interface, washed twice in HBSS, and suspended in complete medium at 2 x 106 cells per ml for the NK assay.
Serologic depletion studies. To identify the cellular source(s) of legionella-induced IFNs, serologic depletions of splenocyte cultures were performed. T-cell-depleted cultures were obtained by incubating 107 whole-spleen cells in 0.1 ml of RPMI 1640 and with 0.05 ml of undiluted anti-Thy-1.2 antibodies for 30 min at 37°C. T cells and LGLs were then lysed by adding complement at a dilution of 1:10 and incubating for an additional 30 min at 37°C. Cells were washed three times in HBSS and suspended in complete medium. T-cell depletion was assessed by measuring mitogenic responses of the residual cells to 5 ,ug of concanavalin A (Sigma) per ml or 10 ,g of E. coli lipopolysaccharide (Sigma) per ml. Cultures were considered to be selectively depleted of T cells if the response to concanavalin A was not above that of cells incubated in medium alone and the response to lipopolysaccharide was not inhibited. Similarly, splenocytes were treated with anti-asialo-GM1 antibodies plus complement to eliminate NK cells (19) or anti-L3T4 antibodies plus complement to eliminate T helper cells (9) . The treated populations were assessed for NK activity as described below. Anti-Thy-1.2 antibody was obtained from Cappell Laboratories (West Chester, Pa.), rabbit anti-asialo-GM1 antibodies were obtained from Wako Chemicals (Dallas, Tex.), and anti-L3T4 antibodies were obtained from the culture supernatant fluids of a hybridoma, GK1.5 (9) . Rabbit complement, used with the above antibodies to accomplish lysis, was obtained from Cedarlane.
Purification of LGLs. As an alternative method to determine the cellular source(s) of legionella-induced IFNs, separations of the nonadherent splenocytes were performed, in addition to the serologic depletion studies described above. Nonadherent cells recovered from the plastic wells were passed through nylon-wool columns to remove residual macrophages and B cells (17) . A 10-ml column containing 1 g of brushed nylon-wool was incubated at 37°C in HBSS plus 10% fetal calf serum for 1 h, and 1.5 x 108 cells in 2 ml of warm complete medium were then loaded onto the column. The column was incubated at 37°C for 45 min, and nylonwool nonadherent (NWNA) cells were then eluted with 25 ml of warm complete medium. The recovery was usually 18 to 23% of the original number of cells applied to the column, and treatment of a sample of the eluted cells with anti-Thy- The results indicated that depletion of whole splenocyte populations with antibodies to Thy-1.2 and asialo-GM1 abrogated the induction of IFN by the vaccine in the presence or absence of IL-2 (Table 1) . However, treatment of cultures with antibodies to L3T4, a helper T-cell marker, did not affect IFN production or NK activity. It was also noted that NWNA cells could produce IFN upon stimulation, but for optimal levels to be achieved, the presence of macrophages at concentrations of about 10% of the total lymphoid cells was required. Nylon-wool adherent cells, which are primarily composed of B cells, were not found to produce IFN either in the presence or absence of IL-2 or macrophages (data not shown). The IFN induced appeared to be of the gamma type because monoclonal anti-IFN--y antibodies completely neutralized all activity in the IFNcontaining supernatants.
Purification of LGLs for IFN induction. Since the previous studies indicated that Thy-1.2-positive, asialo-GM1-positive cells were responsible for the production of IFN--y upon stimulation with L. pneumophila antigens and since NWNA cells appeared to contain the responsive population of cells, it was thought that NK or NK-like cells were the potential source of IFN--y. To further purify the LGL subpopulation of lymphocytes, Percoll density gradient separations were performed with the NWNA cells. The purified cell fractions were then stimulated with L. pneumophila vaccine in the presence or absence of IL-2 or macrophages. Figure 1 shows the IFN activity induced by whole-cell vaccine in the various cell populations isolated from the different Percoll fractions. The results demonstrate that IFN production was maximal in cells from fractions 2 to 3, which also correlated with the highest NK activity as measured by the cytolytic activity of freshly isolated cells against YAC-1 tumor target cells. These results indicate that IFN was produced by NK or NK-like cells, since Percoll purification procedures of LGLs substantially increased production and depletion studies Percoll fractions were incubated in medium alone (stippled areas) or in the presence of IL-2 (20 U/ml) (represented by total bar height) and stimulated with 105 killed cells per ml. Lymphocytes were also incubated in the absence (-) or presence (+) of 10% macrophages in the culture. The media were harvested after 24 h of incubation and assayed for IFN activity. Bar using antibodies to asialo-GM1 totally eliminated the cells responsible for IFN production. The bacterial vaccine consistently stimulated the induction of IFN, and the presence of macrophages and IL-2 augmented the levels produced.
In vitro induction of NK activity by L. pneumophila. Since the studies described above showed that NK or NK-like cells were responsible for the production of IFN--y after stimulation with L. pneumophila antigens, the possibility that L. pneumophila could activate NK activity was examined. For these experiments, NWNA cells or cells purified from Percoll fractions were stimulated in vitro with L. pneumophila vaccine for 24 h. The splenocytes were harvested, washed in fresh medium, and assessed for NK activity in a 4-h 51Cr release assay using YAC-1 tumor cells as targets. As with the experiments on the induction of IFN by L. pneumophila components, the effects of exogenous IL-2 and macrophages on the generation of NK activity were explored. The results are shown in Fig. 2 . The basal level of cytolytic activity of murine spleen cells which were incubated for 24 h in medium alone was always less than 2 LU/106 cells. As with the production of IFN, the maximal L. pneumophila-induced NK activity was found in fraction 3, although the addition of macrophages to the mixture did not appear to be as important as it was for IFN production. IL-2 could activate NK activity alone, and the levels of NK activity seen with the combination of vaccine and IL-2 appeared to be additive rather than synergistic. However In vivo induction of IFN-y and NK activity by L. pneumophila. We previously reported that IFN-y was found in the circulation and at the site of local inoculation during L. pneumophila infection of mice (4) . Since NK cells were activated by L. pnei(mophila vaccine in vitro, the induction of NK activity during the course of in vivo infection was also examined. The results in Table 2 show the in vivo kinetics of IFN production and NK activation in the circulation and at the local site of infection during i.t. inoculation of mice. The kinetics of IFN production in both the lung lavage fluid and serum was similar to that reported previously (4), and increased levels of IFN appeared to correlate with augmented NK activity of PBLs and lung leukocytes. 0  65  <10  44  <10  24  117  30 10  77  30 5  48  358  15 5  123  20 10  72  164  <10  90  10 5  120  130  <10  48  <10 Mice were inoculated i.t. with 3 x 106 bacteria per animal (sublethal dose). ' At the indicated times postinoculation, lung lavage fluid was obtained for the IFN assay and lung leukocytes were obtained from separate animals for the assay for NK activity. Each result of NK activity is from a representative of four experiments that were performed. IFN activity is expressed as the mean ± the standard error of the mean. ' Sera were obtained for the IFN assay at the indicated times, and PBLs were collected from heparinized blood from separate animals for the assay for NK activity. To further assess the effect of i.t. infection by L. pneumophila on NK activity, three populations of lymphoid cells were assayed: spleen cells, PBLs, and lung leukocytes. The effect of an approximate lethal (107 bacteria per animal) versus sublethal (3 x 106 bacteria per animal) infection on NK activity was also investigated. Figure 3 illustrates the effect of L. pneuimophila infection on NK activity in the spleen cells of lethally and sublethally infected animals. The injection of pyrogen-free salipe had no significant effect on NK activity, while lethally infected mice were suppressed on days 2 and 3. In contrast, sublethally infected animals were found to have augmented NK activity on days 1 and 2, with levels returning to normal by day 3. The NK activity in PBLs shows a slightly different pattern (Fig. 4) . Lethally infected animals demQnstrated augmented activity at days 1 and 2, with levels then falling. In sublethally infected animals, NK activity reached 300% of the level in uninfected controls and was maximal at 2 days postinoculation. The augmentation in the lung leukocytes of sublethally infected mice at day 2 postinoculation was even more pronounced than in PBLs of the same mice (Fig. 5) , with maximal levels reaching 550% of the levels in control mice. The lung leukocytes of lethally infected mice also demonstrated augmented NK activity until day 3, with levels then falling. It should be noted that mice begin to succumb to lethal infection by legionella by day 3 po$tinoculation and were therefore unavailable for the NK assay beyond that point.
DISCUSSION
We previously reported that legionella could induce the production of IFN--y both in vitro (5) and in vivo (4) . In this study, we extended our investigation to show that the asialo-GM1+ or NK-like cells are the source of IFN-y in mouse splenocyte cultures. Additionally, L. pneumophila antigens stimulated NK activity in the same Percoll-fractionated cells that produced IFN. It was noted that the presence of macrophages or IL-2 resulted in maximal production of both IFN--y and NK activity. While NK cell activation is not macrophage dependent, the enhanced NK activity in the presence of macrophages here may be mediated by IFN-y in an autostimulatory fashion.
During in vivo infection of mice by L. pneumophila, there also appeared to be augmentation of NK activity, with the largest changes found in the lung, which is the site of inoculation. There also appeared to be a mobilization of NK cells in the lungs of infected mice. For example, in addition to the augmented cytolytic activity present, the total number of leukocytes recovered from infected lungs was 20-to 25-fold higher than that recovered from uninfected mice (data not shown). The accumulation of LGLs has also been reported in the lungs of virally infected mice in response to a chemotactic stimulus (25) .
LGLs are also chemoattracted to f-met-leu-phe (25), a bacterial product which is likely present during infection by legionella.
The results of these experiments indicate that L. pneumophila antigens stimulate NK cell function in at least two ways. These cells could respond to bacterial stimulation by producing IFN--y both in vivo and in vitro. In addition, the (20, 27) , and IFN--y has been shown to have macrophage-activating functions (31) .
The results of this study suggest a myriad of responses which may result after stimulation of NK cells by L. pneumophila bacteria. Whether augmented cytotoxic activity which occurs as a consequence of bacterial infections has a direct effect on the pathogenesis of the disease is yet to be determined. However, the production of IFN--y could lead to augmented bactericidal capacity of both macrophages and polymorphonuclear leukocytes, thereby 'accelerating the clearance of the bacteria from the host. Thus, the responses of NK cells to bacterial stimulation may vary from direct lysis of bacterially infected cells (6, 21) to augmentation of macrophage and polymorphonuclear leukocyte bactericidal properties via the production of soluble factors such as IFNs and tumor necrosis factor. ACKNOWLEDGMENT This work was supported by Public Health Service grant AI-16618 from the National Institute of Allergy and Infectious Diseases.
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